Analysis of change in blood leukocyte count by anticoagulant in leukocytapheresis for rheumatoid arthritis
Not Applicable
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000031850
- Lead Sponsor
- Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have active infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood leukocyte count at baseline, finished and 4weeks after leukocytapheresis.
- Secondary Outcome Measures
Name Time Method Swollen joint count, Tender joint count, C-reactive protein, DAS28(CRP) at baseline, finished and 4weeks after leukocytapheresis.